As of 2025-10-17, the EV/EBITDA ratio of OptiBiotix Health PLC (OPTI.L) is -3.64. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. OPTI.L's latest enterprise value is 8.10 mil GBP. OPTI.L's TTM EBITDA according to its financial statements is -2.23 mil GBP. Dividing these 2 quantities gives us the above OPTI.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.5x - 17.5x | 13.1x |
| Forward P/E multiples | 11.7x - 17.8x | 13.8x |
| Fair Price | (23.92) - (36.43) | (27.74) |
| Upside | -362.9% - -500.3% | -404.8% |
| Date | EV/EBITDA |
| 2025-10-16 | -3.64 |
| 2025-10-15 | -3.55 |
| 2025-10-14 | -3.72 |
| 2025-10-13 | -3.96 |
| 2025-10-10 | -4.20 |
| 2025-10-09 | -4.17 |
| 2025-10-08 | -4.41 |
| 2025-10-07 | -4.42 |
| 2025-10-06 | -4.42 |
| 2025-10-03 | -4.43 |
| 2025-10-02 | -4.52 |
| 2025-10-01 | -4.76 |
| 2025-09-30 | -4.42 |
| 2025-09-29 | -4.42 |
| 2025-09-26 | -4.43 |
| 2025-09-25 | -4.17 |
| 2025-09-24 | -4.18 |
| 2025-09-23 | -4.18 |
| 2025-09-22 | -3.93 |
| 2025-09-19 | -3.85 |
| 2025-09-18 | -4.06 |
| 2025-09-17 | -4.06 |
| 2025-09-16 | -4.07 |
| 2025-09-15 | -4.19 |
| 2025-09-12 | -4.20 |
| 2025-09-11 | -4.17 |
| 2025-09-10 | -4.18 |
| 2025-09-09 | -4.18 |
| 2025-09-08 | -4.19 |
| 2025-09-05 | -4.43 |
| 2025-09-04 | -4.58 |
| 2025-09-03 | -4.64 |
| 2025-09-02 | -4.88 |
| 2025-09-01 | -4.88 |
| 2025-08-29 | -4.90 |
| 2025-08-28 | -4.87 |
| 2025-08-27 | -4.88 |
| 2025-08-26 | -4.88 |
| 2025-08-22 | -4.90 |
| 2025-08-21 | -4.99 |
| 2025-08-20 | -5.17 |
| 2025-08-19 | -5.29 |
| 2025-08-18 | -5.46 |
| 2025-08-15 | -4.90 |
| 2025-08-14 | -4.64 |
| 2025-08-13 | -4.18 |
| 2025-08-12 | -4.18 |
| 2025-08-11 | -4.19 |
| 2025-08-08 | -4.20 |
| 2025-08-07 | -4.41 |